top of page
PsySonics

Immersive sound for your
psychedelic-assisted therapy

"It's a leap forward for therapeutic sound."
- Dr. Raymond Turpin, Psy.D.

01

First sound of its kind

This groundbreaking immersive sound is engineered exclusively for mental-health clinicians and their patients undergoing psychedelic-assisted therapy (PAT) with Ketamine, Psilocybin, and MDMA treatments. 

02

Clinician focused, patient informed

Our sound is a paradigm shift, providing clinicians with an effortless, uninterrupted immersive sound that transcends the limitations of conventional music and playlists.  It brings science and technology together in one place so that clinicians, mental health institutions, and patients benefit from the latest innovations in immersive sound. 

03

Our sound is different...for a reason

PsySonics' sound provides a sanctuary for patients, unearthing the profound significance of their therapeutic journey. Where the status quo playlists fall short, PsySonics ensures that the profound power of PAT is neither diluted nor compromised — because those needing healing deserve nothing less than extraordinary.

Story on MDMA

PsySonics' Founder and CEO, Rogers Masson, speaks about his journey on NPR with journalist, Will Stone.  

Read the full article here.

Listen here...

NPR - MDMA Win Approval?Artist Name
00:00 / 04:01

What clinicians are saying...

Raymond Turpin
"Our patient had a profound experience while using your sound. She was able to effortlessly and seamlessly move between focus and going inside the medicine."

Dr. Raymond Turpin, PhD

Lead Therapist at Pearl Psychedelic Institute

MAPS FDA clinical trials for MDMA

Making a difference for patients...

"It felt like the sound was inside me, supporting me while I processed my trauma."

Patient in MDMA Clinical Trial

Recommended by leaders in psychedelic-assisted therapy

The Pearl Institute

The Pearl Psychedelic Institute,

the first US site to be authorized for MDMA-assisted therapy in PTSD

MAPs

Our sound was used during the MAPS Expanded Access FDA program for investigational treatment of MDMA-assisted therapy for PTSD

A Better Way

PsySonics' Founder and CEO, Rogers Masson was a patient in the MAPS/FDA trials for MDMA. Inspired by his personal experience and insights in the trials, Rogers drew from his extensive expertise in sound engineering and immersive audio to create something truly innovative and new.

The result is PsySonics.

We'd love to hear from you

Contact us to learn more about PsySonics or talk with the team.
pyrofox5_an_acoustic_wave_form_as_a_watercolor_painting_a98ba0ea-3cc6-49b7-b302-6fc109da32

Thank you for contacting us!

  • LinkedIn
Connect with us on 
bottom of page